The Department of Defense offers the NFRP Exploration – Hypothesis Development Award for groundbreaking NF research, encouraging innovative, high-risk concepts. This grant aims to support the initial exploration of new ideas with the potential for significant scientific impact. Applicants must present a well-formulated, testable hypothesis supported by strong rationale and design. The research should be innovative, challenging existing paradigms or offering novel perspectives. Preliminary or published data is beneficial but not mandatory. The Principal Investigator must clearly explain how the proposed project introduces creativity and advancement in the field of Neurofibromatosis research. Deadline: Jul 27, 2015.
Opportunity ID: 276382
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-15-NFRP-EHDA |
| Funding Opportunity Title: | DoD Neurofibromatosis Exploration – Hypothesis Development Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 8 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | May 06, 2015 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Jul 27, 2015 |
| Current Closing Date for Applications: | Jul 27, 2015 |
| Archive Date: | Aug 26, 2015 |
| Estimated Total Program Funding: | $1,280,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The NFRP Exploration – Hypothesis Development Award supports the initial exploration of innovative, high-risk, high-gain, and potentially groundbreaking concepts in NF research. Studies supported by this award mechanism are expected to lay the groundwork for future avenues of scientific investigation. The proposed research project should include a well-formulated, testable hypothesis based on strong scientific rationale and study design. The presentation of preliminary and/or published data is encouraged, but not required. The proposed research project should be innovative. Innovative research may introduce a novel paradigm, challenge existing paradigms, examine existing problems from novel perspectives, or exhibit other highly creative qualities. Research that is an incremental advance upon published data is not considered innovative and is not consistent with the intent of this award mechanism. It is the responsibility of the Principal Investigator (PI) to clearly and explicitly articulate how the proposed research project is innovative in the field of NF. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
CDMRP Help Desk
Phone: 301-682-5507 Email:help@eBRAP.org |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 276382 Full Announcement-1 -> nfrp_fy15_ehda_pa_gg.pdf
Packages
| Agency Contact Information: | CDMRP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.420 | PKG00216633 | May 06, 2015 | Jul 27, 2015 | View |
Package 1
Mandatory forms
276382 RR_SF424_2_0-2.0.pdf
276382 RR_Budget_1_3-1.3.pdf
276382 RR_KeyPersonExpanded_2_0-2.0.pdf
276382 PerformanceSite_2_0-2.0.pdf
Optional forms
276382 RR_SubawardBudget30_1_3-1.3.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
